131 related articles for article (PubMed ID: 23796713)
1. MicroRNA-124 targets CCNA2 and regulates cell cycle in STHdh(Q111)/Hdh(Q111) cells.
Das E; Jana NR; Bhattacharyya NP
Biochem Biophys Res Commun; 2013 Jul; 437(2):217-24. PubMed ID: 23796713
[TBL] [Abstract][Full Text] [Related]
2. Delayed Cell Cycle Progression in STHdh(Q111)/Hdh(Q111) Cells, a Cell Model for Huntington's Disease Mediated by microRNA-19a, microRNA-146a and microRNA-432.
Das E; Jana NR; Bhattacharyya NP
Microrna; 2015; 4(2):86-100. PubMed ID: 26165466
[TBL] [Abstract][Full Text] [Related]
3. Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biology.
Choudhury KR; Das S; Bhattacharyya NP
J Proteomics; 2016 Jan; 132():155-66. PubMed ID: 26581643
[TBL] [Abstract][Full Text] [Related]
4. Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington's disease.
Ghose J; Sinha M; Das E; Jana NR; Bhattacharyya NP
PLoS One; 2011; 6(8):e23837. PubMed ID: 21887328
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of system xc(-) expression induced by mutant huntingtin in a striatal neuronal cell line and in R6/2 mice.
Frederick NM; Bertho J; Patel KK; Petr GT; Bakradze E; Smith SB; Rosenberg PA
Neurochem Int; 2014 Oct; 76():59-69. PubMed ID: 25004085
[TBL] [Abstract][Full Text] [Related]
6. Altered microRNAs in STHdh(Q111)/Hdh(Q111) cells: miR-146a targets TBP.
Sinha M; Ghose J; Das E; Bhattarcharyya NP
Biochem Biophys Res Commun; 2010 Jun; 396(3):742-7. PubMed ID: 20451497
[TBL] [Abstract][Full Text] [Related]
7. Activation of Elk-1 participates as a neuroprotective compensatory mechanism in models of Huntington's disease.
Anglada-Huguet M; Giralt A; Perez-Navarro E; Alberch J; Xifró X
J Neurochem; 2012 May; 121(4):639-48. PubMed ID: 22372926
[TBL] [Abstract][Full Text] [Related]
8. Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity.
Xifró X; Anglada-Huguet M; Rué L; Saavedra A; Pérez-Navarro E; Alberch J
Mol Neurodegener; 2011 Oct; 6():74. PubMed ID: 22041125
[TBL] [Abstract][Full Text] [Related]
9. Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells.
Xifró X; García-Martínez JM; Del Toro D; Alberch J; Pérez-Navarro E
J Neurochem; 2008 Jun; 105(5):1596-612. PubMed ID: 18221365
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line.
Kong PJ; Kil MO; Lee H; Kim SS; Johnson GV; Chun W
Neurol Res; 2009 Feb; 31(1):77-83. PubMed ID: 18691453
[TBL] [Abstract][Full Text] [Related]
11. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.
Jin YN; Yu YV; Gundemir S; Jo C; Cui M; Tieu K; Johnson GV
PLoS One; 2013; 8(3):e57932. PubMed ID: 23469253
[TBL] [Abstract][Full Text] [Related]
12. PH domain leucine-rich repeat protein phosphatase 1 contributes to maintain the activation of the PI3K/Akt pro-survival pathway in Huntington's disease striatum.
Saavedra A; García-Martínez JM; Xifró X; Giralt A; Torres-Peraza JF; Canals JM; Díaz-Hernández M; Lucas JJ; Alberch J; Pérez-Navarro E
Cell Death Differ; 2010 Feb; 17(2):324-35. PubMed ID: 19745829
[TBL] [Abstract][Full Text] [Related]
13. Long-term memory deficits in Huntington's disease are associated with reduced CBP histone acetylase activity.
Giralt A; Puigdellívol M; Carretón O; Paoletti P; Valero J; Parra-Damas A; Saura CA; Alberch J; Ginés S
Hum Mol Genet; 2012 Mar; 21(6):1203-16. PubMed ID: 22116937
[TBL] [Abstract][Full Text] [Related]
14. The common inhaled anesthetic isoflurane increases aggregation of huntingtin and alters calcium homeostasis in a cell model of Huntington's disease.
Wang Q; Liang G; Yang H; Wang S; Eckenhoff MF; Wei H
Toxicol Appl Pharmacol; 2011 Feb; 250(3):291-8. PubMed ID: 21059370
[TBL] [Abstract][Full Text] [Related]
15. Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells--protective effect of cystamine and creatine.
Ribeiro M; Silva AC; Rodrigues J; Naia L; Rego AC
Toxicol Sci; 2013 Dec; 136(2):487-99. PubMed ID: 24008831
[TBL] [Abstract][Full Text] [Related]
16. Glutamate transporter expression and function in a striatal neuronal model of Huntington's disease.
Petr GT; Bakradze E; Frederick NM; Wang J; Armsen W; Aizenman E; Rosenberg PA
Neurochem Int; 2013 Jun; 62(7):973-81. PubMed ID: 23507328
[TBL] [Abstract][Full Text] [Related]
17. Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington's disease.
Ribeiro FM; Paquet M; Ferreira LT; Cregan T; Swan P; Cregan SP; Ferguson SS
J Neurosci; 2010 Jan; 30(1):316-24. PubMed ID: 20053912
[TBL] [Abstract][Full Text] [Related]
18. Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis.
Reis SA; Thompson MN; Lee JM; Fossale E; Kim HH; Liao JK; Moskowitz MA; Shaw SY; Dong L; Haggarty SJ; MacDonald ME; Seong IS
Hum Mol Genet; 2011 Jun; 20(12):2344-55. PubMed ID: 21447599
[TBL] [Abstract][Full Text] [Related]
19. Metabolic state determines sensitivity to cellular stress in Huntington disease: normalization by activation of PPARγ.
Jin YN; Hwang WY; Jo C; Johnson GV
PLoS One; 2012; 7(1):e30406. PubMed ID: 22276192
[TBL] [Abstract][Full Text] [Related]
20. Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington's disease.
Molero AE; Gokhan S; Gonzalez S; Feig JL; Alexandre LC; Mehler MF
Proc Natl Acad Sci U S A; 2009 Dec; 106(51):21900-5. PubMed ID: 19955426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]